Business
BIG news for Cybin Inc. (CYBN: NEO) (CLXPF: OTC) and Numinus Wellness (NUMI: NEO) (LKYSF: OTC). First and foremost, Numinus...
Cybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."...
NCT will utilize Numinus' expertise in psychedelic-assisted therapy to create a specialization in the application of psychedelics in the field...
In today's episode, we'll be interviewing CEO and Chairman of TRYP Therapeutics, Greg Mckee. Thus far, this is one of...
This week in psychedelic business news: Companies embrace the psychedelic aspects of VR, Braxia trains therapists in psychedelic best practices,...
Havn Life Sciences is expanding its psilocybin cultivation in Jamaica where the psychedelic mushrooms are legal to grow....
BIG news for Mydecine (MYCO : NEO) (MYCOF: OTC) and Numinus Wellness (NUMI: NEO) (LKYSF : OTC). But The BIGGER...
THE MINDMED VS. ATAI discussion you need to hear! Prior to atai's IPO on the NASDAQ stock exchange, we repeatedly...
This week in psychedelic business news: A next-gen psychedelic for stroke care, a major merger, and two more companies list...
Former Food and Drug Administration division director Dr. Thomas Laughren has joined the psychedelic life sciences team at Cybin....